GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hinova Pharmaceuticals Inc (SHSE:688302) » Definitions » 6-1 Month Momentum %

Hinova Pharmaceuticals (SHSE:688302) 6-1 Month Momentum % : -47.28% (As of Jun. 16, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Hinova Pharmaceuticals 6-1 Month Momentum %?

6-1 Month Momentum % is the total return of the stock from 6-month ago to 1-month ago. As of today (2024-06-16), Hinova Pharmaceuticals's 6-1 Month Momentum % is -47.28%.

The industry rank for Hinova Pharmaceuticals's 6-1 Month Momentum % or its related term are showing as below:

SHSE:688302's 6-1 Month Momentum % is ranked worse than
87.06% of 1522 companies
in the Biotechnology industry
Industry Median: -5.57 vs SHSE:688302: -47.28

Competitive Comparison of Hinova Pharmaceuticals's 6-1 Month Momentum %

For the Biotechnology subindustry, Hinova Pharmaceuticals's 6-1 Month Momentum %, along with its competitors' market caps and 6-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hinova Pharmaceuticals's 6-1 Month Momentum % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hinova Pharmaceuticals's 6-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Hinova Pharmaceuticals's 6-1 Month Momentum % falls into.



Hinova Pharmaceuticals  (SHSE:688302) 6-1 Month Momentum % Calculation

6-1 Month Momentum % is calculated as following:

6-1 Month Momentum %=( Price 1-month ago / Price 6-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hinova Pharmaceuticals  (SHSE:688302) 6-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 6-1 Month Momentum % measures the total return to a stock over the past six months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Hinova Pharmaceuticals 6-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Hinova Pharmaceuticals's 6-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Hinova Pharmaceuticals (SHSE:688302) Business Description

Traded in Other Exchanges
N/A
Address
No. 5 Keyuan South Road, No. 2 and 3, 4th Floor, Building 1, Rongyao Building, High-tech Zone, Sichuan Province, Chengdu, CHN, 610041
Hinova Pharmaceuticals Inc is an international drug company based on technology platforms such as deuterium and PROTAC, aiming to develop Best-in-class and First-in-class drugs with major clinical needs. The company focuses on the research and development of drugs in therapeutic areas such as oncology and metabolic diseases, focusing on providing safe, effective and affordable drugs for patients, and is committed to the development and production of drugs with global rights and interests.

Hinova Pharmaceuticals (SHSE:688302) Headlines

No Headlines